Streetbeat News

Assets

PDLB

Ponce Financial Group, Inc. (NASDAQ:PDLB), the holding company for Ponce Bank, has received approval for a grant of $451,025 from the Community Development Financial Institutions (CDFI) Bank Enterprise Award Program. The bank also received the previously announced $3.7 million from the CDFI Equitable Recovery Program (ERP). The funds are to be used for providing loans, investments, and financial services to distressed communities and help them recover from the impact of the COVID-19 pandemic.

Portfolio Pulse from Benzinga Newsdesk

September 27, 2023 | 8:43 pm

NXPI

NXP Semiconductors (NASDAQ:NXPI) has outperformed the market over the past 5 years by 10.37% on an annualized basis, producing an average annual return of 18.25%. If an investor had bought $1000 of NXPI stock 5 years ago, it would be worth $2,313.30 today.

Portfolio Pulse from Benzinga Insights

September 27, 2023 | 8:30 pm

APH

Amphenol (NYSE:APH) has outperformed the market over the past 10 years by 5.89% on an annualized basis, producing an average annual return of 15.55%. If an investor had bought $1000 of APH stock 10 years ago, it would be worth $4,257.43 today.

Portfolio Pulse from Benzinga Insights

September 27, 2023 | 8:30 pm

CE

Celanese has completed the formation of Nutrinova, a Food Ingredients joint venture with Mitsui & Co., Ltd. Celanese contributed its Food Ingredients business assets, technology, and employees, retaining a 30% stake. Mitsui acquired the remaining 70% stake for $472.5 million. The company plans to use the transaction proceeds to execute its deleveraging plan in the third quarter.

Portfolio Pulse from Benzinga Newsdesk

September 27, 2023 | 8:28 pm

HUM

A significant amount of unusual options activity has been observed for Humana (NYSE:HUM), with a bearish stance taken by a majority of investors. The price range targeted by these investors over the last three months is from $410.0 to $610.0. The current price of HUM is $493.58, up 0.12%. Cantor Fitzgerald has downgraded its action to Overweight with a price target of $597, while Morgan Stanley maintains their Overweight rating with a price target of $624.

Portfolio Pulse from Benzinga Insights

September 27, 2023 | 8:16 pm

BMY

Bristol-Myers Squibb (NYSE:BMY) has seen unusual options activity, with a large position indicating a bullish stance. The sentiment among these big-money traders is split between 70% bullish and 30% bearish. The targeted price range for Bristol-Myers Squibb over the last 3 months is from $50.0 to $65.0. The company's stock price is currently down by 1.11% at $57.89. Analysts from Cantor Fitzgerald, TD Cowen, and Truist Securities have given price targets of $75, $66, and $84 respectively.

Portfolio Pulse from Benzinga Insights

September 27, 2023 | 8:16 pm

MSOS

PSIL

VICE

YOLO

The Senate Banking Committee has approved the Secure and Fair Enforcement Regulation (SAFER) Banking Act, a significant step towards cannabis reform. This regulatory milestone would allow legal cannabis businesses to access banks and financial institutions. The panel discussion at the Benzinga Cannabis Capital Conference included representatives from Poseidon Investment Management, AdvisorShares, Entourage Effect Capital, and Eminence Capital. The panelists discussed the potential for increased investment in the cannabis sector and the expected consolidation of the industry.

Portfolio Pulse from Jelena Martinovic

September 27, 2023 | 8:08 pm

CVS

A significant investor has taken a bullish stance on CVS Health (NYSE:CVS), with 50% of recent trades being bullish and 50% bearish. The total amount for puts is $455,299 and for calls is $356,800. Whales have been targeting a price range from $65.0 to $80.0 for CVS Health over the last 3 months. The current price of CVS is down -2.22% at $69.75. Several experts have given positive ratings and price targets for CVS, ranging from $80 to $87.

Portfolio Pulse from Benzinga Insights

September 27, 2023 | 8:01 pm

PDD

PDD Holdings (NASDAQ:PDD) has outperformed the market over the past 5 years, producing an average annual return of 29.87%. If an investor had bought $1000 of PDD stock 5 years ago, it would be worth $3,423.98 today.

Portfolio Pulse from Benzinga Insights

September 27, 2023 | 8:00 pm

CRGY

Stephens & Co. analyst Mike Scialla initiated coverage on Crescent Energy Company (NYSE:CRGY) with an Overweight rating and a price target of $17. The analyst believes the company is well-positioned for growth due to its low production base decline rates, strong balance sheet, and underappreciated asset quality. However, a significant decline in oil and natural gas prices could impact the company's near-term cash flow and EBITDA estimates.

Portfolio Pulse from Lekha Gupta

September 27, 2023 | 7:47 pm